SEC Form 4 · accession 0001205535-15-000005
Sesen Bio, Inc. · SESN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John J McCabe
Officer — Senior Vice President, Finance
Period of report
Aug 12, 2015
Accepted (ET)
Aug 14, 2015 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001485003
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 12, 2015 | A | 10,000 | $0.00 | A | 10,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $4.09 | Aug 12, 2015 | A | 20,000 | A | — | Aug 11, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1Represents restricted stock units which vest as to 33.33% of the original number of restricted stock units granted to Mr. McCabe on each of the six-month, twelve-month and eighteen-month anniversaries of the grant date.
- F2This option was granted on August 12, 2015 and vests over four years, with 6.25% of the shares underlying the option vesting at the end of each successive three-month period after August 1, 2015 until August 1, 2019.